Angeline Lim

Molecular Devices (United Kingdom) — United Kingdom

Medicine · Health Sciences

17h-index1.1kcitations35works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mosquito-borne diseases and control(6), Microtubule and mitosis dynamics(5), Monoclonal and Polyclonal Antibodies Research(5), COVID-19 Clinical Research Studies(4), SARS-CoV-2 and COVID-19 Research(4)

Publications35 total

Automation of Complex Patient-Derived Organoid (PDO) Culture and Screen
2026Open Access
Abstract 5198: Semi-automated, scaffold-free organoid workflow for the T cell screening assay using AI
Cancer Research·2025
Abstract 2060: Automation of 3D cancer spheroid assay for compound screening
Cancer Research·2024
Abstract 1514: A novel workflow to assess the T-cell and patient-derived organoid interaction
Cancer Research·2024
Abstract 4919: AI-enabled hit selection of drug screening on human pancreatic cancer organoids
Cancer Research·2024
Abstract 5362: AI-enabled novel workflow to evaluate T-cell activity <i>in vitro</i> using 3D spheroid models
Cancer Research·2023
Abstract 199: Novel platform for automation of high throughput drug discovery using patient derived colorectal cancer organoids
Cancer Research·2023· 1 cited
Evaluating Drug Response in 3D Triple Negative Breast Cancer Tumoroids with High Content Imaging and Analysis
Research Square (Research Square)·2022· 3 citedOpen Access
The IDentif.AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimens
npj Digital Medicine·2022· 24 citedOpen Access
Abstract 180: Automation and high content imaging of 3D triple negative breast cancer patient-derived tumoroids assay for compound screening
Cancer Research·2022
Dissection and Direct Imaging of Axonal Transport in Drosophila Segmental Nerves
Methods in molecular biology·2022· 3 cited
The IDentif.AI 2.0 Pandemic Readiness Platform: Rapid Prioritization of Optimized COVID-19 Combination Therapy Regimens
2021· 2 citedOpen Access
The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody
PLoS ONE·2021· 103 citedOpen Access
The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody
2020· 32 citedOpen Access
NTUC Foodfare
2019
Two kinesins drive anterograde neuropeptide transport
Molecular Biology of the Cell·2017· 51 citedOpen Access
Singapore
2017
Structural Mimicry of the Dengue Virus Envelope Glycoprotein Revealed by the Crystallographic Study of an Idiotype–Anti-idiotype Fab Complex
Journal of Virology·2017· 6 citedOpen Access
Targeting Epstein-Barr virus–transformed B lymphoblastoid cells using antibodies with T-cell receptor–like specificities
Blood·2016· 22 citedOpen Access
Action Research Applied with Two Single Case Studies
Palgrave Macmillan eBooks·2015
page 1 of 2Next →

Frequent Co-authors

Brendon J. Hanson(13), Paul A. MacAry(8), Conrad En Zuo Chan(7), Oksana Sirenko(7), Zhisong Tong(6), Eng Eong Ooi(5), Hwee Cheng Tan(4), De Hoe Chye(4), Soh Ha Chan(3), Annie Hoi Yi Chan(3), Shee‐Mei Lok(3), Kuan Rong Chan(3), Summer L. Zhang(3), Subhash G. Vasudevan(3), William M. Saxton(3), David Chien Lye(3), En Wei Teo(2), Angelia Chow(2), Shirley G. K. Seah(2), Shane Massey(2)